Clinical Trial Details


Back to Clinical Trials Database

SPECTAlung: Screening Patients with thoracic tumors for Efficient Clinical Trial Access

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 22-May-2015
Date Step1 close: 18-Jun-2019
Date Step2 close: 18-Jun-2019
Data management at EORTC Yes
Design Cohort
Not randomized / N.A.
Study Staff Benjamin Besse (Study Coordinator) , Gustave Roussy, Villejuif
Maarten Caspers (Data Manager) , EORTC Headquarters, Brussels
Lieve Dirix (Clinical Operations Manager) , EORTC Headquarters, Brussels
Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels
Baktiar Hasan (Statistician) , EORTC Headquarters, Brussels
Marie Morfouace (Clinical Scientist) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Delphine Sartori (Data Manager) , EORTC Headquarters, Brussels
Maira Seini (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels
Katheline Vander Heggen (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Type of cancer Lung
Participating groups EORTC Lung Cancer Group
EORTC Pathobiology Group
Recruiting centers CHU Toulouse - Hopital Larrey (Toulouse, France)
CHU de Lyon - Hopital Louis Pradel (Bron, France)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Gustave Roussy (Villejuif, France)
Hopital Nord (APHM) (Marseille, France)
Hospital Universitario 12 De Octubre (Madrid, Spain)
Institut Jules Bordet-Hopital Universitaire ULB (Brussels, Belgium)
Medical University Of Gdansk (Gdansk, Poland)
Ospedale S. Luigi Gonzaga - Universita Di Torino (Orbassano-Torino, Italy)
Royal Marsden Hospital - Chelsea, London (London, United Kingdom)
Royal Marsden Hospital - Sutton, Surrey (Surrey, United Kingdom)
St. James'S Hospital (Dublin, Ireland)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
University Clinic Golnik (Golnik, Slovenia)
Vall d'Hebron Institut Oncologia (Barcelona, Spain)
Protocol summary
NCT number NCT02214134
Financial Support External Grant